Table 1.
Summary of key m6A regulators and their roles in wound healing and post-wound events
| Type | Regulator | Biological process | Target | Sample | Biological function | References |
|---|---|---|---|---|---|---|
| m6A writers | METTL3 | Diabetic wound | lncCCKAR-5 | hUCMSCs, mice | METTL3-mediated m6A modification of lncCCKAR-5 enhances the formation of the lncCCKAR5/LMNA/MKRN2 complex and LMNA degradation in hUCMSCs, thereby inhibiting diabetic wound repair | 100 |
| Keloid | Smad3 | HTFs, New Zealand white rabbits | METTL3 promotes TGF-β/Smad signalling by upregulating Smad3, thus enhancing the viability, proliferation, and ECM deposition of HTFs | 124 | ||
| Hair follicle | Wnt, Shh | Mouse skin epidermal progenitors, C57BL/6 mice | METTL3 ablation in epidermal progenitor cells leads to defects in Wnt and Shh signaling pathways, and reduced HF formation | 134 | ||
| Hair follicle | SETD1A, SETD1B, KMT2B, KMT2D | C57BL/6 mice | METTL3-eKO newborn mice have abnormal epidermal development and deformed hair follicles. | 135 | ||
| Keloid | Wnt3a, β-catenin, S100A4 | HSFs, Human keloid tissue | Elevated METTL3 and WTAP upregulate the Wnt/β-catenin/S100A4 pathway in human keloid tissue | 123 | ||
| ZC3H13 | Keloid | HIPK2 | HKFs, Human keloid tissue | Elevated ZC3H13 mediates the m6A modification and stabilisation of HIPK2, thereby promoting HKFs proliferation and accelerating keloid formation | 125 | |
| METTL14 | Wound | PVT1 | Mice | METTL14 modifies lncRNA PVT1 to stabilize MYC, thereby increasing the number of p63-positive basal cells and promoting wound healing | 89 | |
| m6A readers | IGF2BP1 | Diabetic wound | HMGB1 | HUVECs | Increased expression of IGF2BP1 stabilises and increases the expression of HMGB1 mRNA, thereby promoting apoptosis in high glucose-induced HUVECs | 147 |
| IGF2BP2 | Wound | HPSE | HaCaT | IGF2BP2 enhances the stability of HPSE, promotes the proliferation and migration of HaCaT cells, and accelerates wound healing | 91 | |
| Wound | let-7b | HaCaT, Mice | The overexpression of let-7b inhibits the expression of IGF2BP2 in HaCaT cells, resulting in delayed epithelialisation and skin wound healing | 92 | ||
| IGF2BP3 | Wound | circCDK13 | HDFs, HEKs | IGF2BP3 enhances circCDK13 to promote CD44 and c-MYC expression, which enhances the proliferation and migration of HDFs and HEKs and promotes wound healing | 105 | |
| YTHDC1 | Diabetic wound | SQSTM1 | HaCaT, Mice | Downregulation of YTHDC1 in HaCaT cells and mice accelerated SQSTM1 mRNA degradation, leading to delayed diabetic wound healing process | 104 | |
| m6A erasers | ALKBH5 | Hypertrophic scars | COL1A1, COL3A1, ELN | HDFs, Human HTS tissue | Defects in ALKBH5 lead to elevated m6A levels of COL3A1, COL1A1, and ELN, leading to pathological deposition and remodeling of the extracellular matrix | 127 |
| ALKBH5 FTO |
Wound | PELI2 | HaCaT, Mice | ALKBH5 and YTHDF2 promote PELI2 expression, which promotes keratinocyte migration, epithelialization, and skin wound healing. | 97 | |
| FTO | Burn injury | TFPI-2 | HaCaT, Rats | Overexpression of FTO inhibits TFPI-2 expression, which promotes the proliferation of thermally stimulated HaCaT cells and accelerates wound healing in burned rats | 116 | |
| Keloid | COL1A1, α-SMA | HDFs, Human keloid tissue | Overexpression of FTO in HDFs enhances the expression of COL1A1 and α-SMA, thereby promoting keloid formation | 126 | ||
| Sweat gland | Nanog | MSCs | Inhibition of FTO expression by TNF-α leads to down-regulation of Nanog expression as well as a reduced potential for MSCs to differentiate into sweat glands. | 138 |